See more : Kinetiko Energy Limited (KKO.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Goodness Growth Holdings, Inc. (GDNSF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Goodness Growth Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Asset Five Group Public Company Limited (A5.BK) Income Statement Analysis – Financial Results
- Casablanca Group Limited (2223.HK) Income Statement Analysis – Financial Results
- Bee Vectoring Technologies International Inc. (BEE.CN) Income Statement Analysis – Financial Results
- Peako Limited (PKO.AX) Income Statement Analysis – Financial Results
- Orzel Bialy S.A. (OBL.WA) Income Statement Analysis – Financial Results
Goodness Growth Holdings, Inc. (GDNSF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.goodnessgrowth.com
About Goodness Growth Holdings, Inc.
Goodness Growth Holdings, Inc. operates as a physician-led cannabis company in the United States. The company cultivates cannabis in environmentally friendly greenhouses; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other Goodness Growth branded retail dispensaries, as well as third-party dispensaries. As of March 11, 2022, it operated 18 dispensaries, which included 2 in Maryland, 8 in Minnesota, 4 in New Mexico, and 4 in New York; and offered wholesale cannabis products through third-party companies in Arizona, Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 88.13M | 74.63M | 54.45M | 49.21M | 29.96M | 18.46M | 10.87M | 4.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 44.03M | 43.72M | 34.65M | 32.08M | 19.11M | 276.76 | 379.90 | 448.90 | 548.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 44.10M | 30.91M | 19.80M | 17.13M | 10.84M | 18.46M | 10.87M | 4.26M | -548.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 50.04% | 41.42% | 36.36% | 34.80% | 36.19% | 100.00% | 100.00% | 99.99% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 31.58M | 35.45M | 36.31M | 39.14M | 27.67M | 139.07K | 83.60K | 119.80K | 57.93K | 384.06K | 385.25K | 621.53K | 342.58K | 122.31K | 464.63K | 1.35M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 791.98K | 1.07M | 2.53M | 26.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 172.23K | 0.00 | 0.00 | 0.00 |
| SG&A | 32.38M | 36.52M | 38.84M | 39.14M | 27.67M | 139.07K | 83.60K | 119.80K | 57.93K | 384.06K | 385.25K | 621.53K | 342.58K | 122.31K | 464.63K | 1.52M | 2.95M | 51.86K | 58.07K |
| Other Expenses | 7.75M | 1.33M | 1.44M | 1.03M | 2.23M | 277.53 | 378.53 | 447.88 | 549.11 | 491.02 | 0.00 | 0.00 | 0.00 | 3.66K | 45.98K | 9.81K | 268.47K | 51.86K | 58.07K |
| Operating Expenses | 33.52M | 37.85M | 40.28M | 40.17M | 29.91M | 139.34K | 83.97K | 120.25K | 58.47K | 384.55K | 385.25K | 621.53K | 342.58K | 125.97K | 586.91K | 1.70M | 3.21M | 51.86K | 58.07K |
| Cost & Expenses | 77.55M | 81.57M | 74.93M | 72.25M | 49.02M | 139.34K | 83.97K | 120.25K | 58.47K | 384.55K | 385.25K | 621.53K | 342.58K | 125.97K | 586.91K | 1.70M | 3.21M | 51.86K | 58.07K |
| Interest Income | 0.00 | 22.59M | 10.58M | 5.10M | 662.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 315.16 | 628.59 | 0.00 | 8.29K | 3.84K |
| Interest Expense | 31.26M | 22.59M | 10.58M | 5.10M | 5.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.32K | 25.28K | 75.29K | 35.08K | 39.05K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 3.60M | 2.57M | 1.20M | 1.04M | 4.07M | 277.53 | 378.53 | 447.88 | 549.11 | 491.02 | 0.00 | 0.00 | 0.00 | 0.00 | 122.27K | 183.00K | 257.34K | 0.00 | 0.00 |
| EBITDA | 17.04M | -9.96M | -18.87M | -5.96M | -15.47M | -139.07K | -83.60K | -132.24K | -57.24K | -383.53K | -385.25K | -621.53K | -342.58K | -125.97K | -418.34K | -1.51M | -3.77M | -51.86K | -58.07K |
| EBITDA Ratio | 24.88% | -5.85% | -35.42% | -44.72% | -51.64% | -0.75% | -0.77% | -3.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 10.58M | -6.94M | -20.48M | -23.04M | -19.53M | -139.34K | -83.97K | -120.25K | -58.47K | -384.55K | -385.25K | -621.53K | -342.58K | -125.97K | -586.91K | -1.70M | -3.21M | -51.86K | -58.07K |
| Operating Income Ratio | 12.00% | -9.30% | -37.62% | -46.82% | -65.21% | -0.75% | -0.77% | -2.82% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -28.40M | -29.63M | -9.09M | 8.89M | -34.94M | 2.26M | -45.12K | 12.47K | -622.85 | -526.33 | -346.34K | 27.13K | 1.02M | -516.09K | -3.29M | -28.61K | 1.00M | 0.00 | 0.00 |
| Income Before Tax | -17.82M | -36.56M | -29.57M | -14.15M | -57.31M | -139.34K | -83.97K | -107.81K | -59.16K | -385.08K | -731.59K | -594.40K | 673.17K | -642.05K | -3.88M | -1.73M | -2.21M | 0.00 | 0.00 |
| Income Before Tax Ratio | -20.22% | -49.00% | -54.31% | -28.76% | -191.31% | -0.75% | -0.77% | -2.53% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 7.72M | 5.89M | 4.12M | 8.79M | -299.00K | 5.20M | 2.39 | -12.44K | 683.87 | 526.33 | 0.00 | 0.00 | 0.00 | 0.00 | 81.06K | 48.86K | -735.65K | 44.75K | 54.76K |
| Net Income | -25.55M | -42.46M | -33.69M | -22.94M | -57.01M | -139.34K | -83.97K | -107.81K | -59.16K | -385.08K | -731.59K | -594.40K | 673.17K | -642.05K | -3.88M | -1.73M | -2.21M | -44.75K | -54.76K |
| Net Income Ratio | -28.99% | -56.89% | -61.88% | -46.62% | -190.31% | -0.75% | -0.77% | -2.53% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.19 | -0.33 | -0.27 | -0.24 | -0.71 | -0.22 | -0.22 | -0.32 | -0.18 | -1.16 | -2.74 | -3.17 | 23.86 | -32.20 | -230.72 | -116.45 | -243.38 | -8.25 | -81.73 |
| EPS Diluted | -0.19 | -0.33 | -0.27 | -0.24 | -0.71 | -0.22 | -0.22 | -0.32 | -0.18 | -1.16 | -2.74 | -3.17 | 23.86 | -32.20 | -230.72 | -116.45 | -243.38 | -8.25 | -81.73 |
| Weighted Avg Shares Out | 135.24M | 128.13M | 123.81M | 97.55M | 80.82M | 641.97K | 380.18K | 332.73K | 332.73K | 332.73K | 267.43K | 187.59K | 28.22K | 19.94K | 16.81K | 14.86K | 9.07K | 5.43K | 670.00 |
| Weighted Avg Shares Out (Dil) | 135.24M | 128.13M | 123.81M | 97.55M | 80.82M | 641.97K | 380.18K | 332.73K | 332.73K | 332.73K | 267.43K | 187.59K | 28.22K | 19.94K | 16.81K | 14.86K | 9.07K | 5.43K | 670.00 |
Goodness Growth Holdings: Top Pick For Near-Term Investment
Goodness is top pick for near term investment. Anticipate outperforming growth and greater investor awareness while expecting a near term takeout looms. Based on recent M&A transactions and Goodness' position in core markets, believe a takeout warrants at least 2x...
Best Marijuana Stocks To Watch Under $2 Right Now
Top Penny Pot Stocks For Your List In 2022 The post Best Marijuana Stocks To Watch Under $2 Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Marijuana Penny Stocks To Watch In The Second Half Of December
Top Penny Stocks For Your List In December 2021 The post Marijuana Penny Stocks To Watch In The Second Half Of December appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Goodness Growth: Waiting On New York
Goodness Growth didn't report a very good Q3'21 with revenues missing targets by a wide margin. The MSO has a key cannabis license in New York worth far more than the current valuation of the stock.
Making The Case For Mid-Tier MSOs (Podcast)
Making The Case For Mid-Tier MSOs (Podcast)
The Best Marijuana Stocks To Buy? 2 To Watch For Better Trading
2 Marijuana Stocks To Watch Today In 2021 The post The Best Marijuana Stocks To Buy? 2 To Watch For Better Trading appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Best Marijuana Penny Stocks To Watch Today? 2 For Your Watchlist While Pot Stocks Are Down
Are Cannabis Penny Stocks A Buy In November? The post Best Marijuana Penny Stocks To Watch Today? 2 For Your Watchlist While Pot Stocks Are Down appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding...
Goodness Growth Wraps Up $8M Acquisition Of Maryland Dispensary
Science-concentrated cannabis company Goodness Growth Holdings, Inc. (CSE:GDNS) (OTCQX:GDNSF) announced on Monday that its subsidiary, Vireo of Charm City, LLC, has wrapped up the previously-disclosed purchase of all substantial assets of Charm City Medicus, LLC, a medical cannabis dispensary in...
Marijuana Stocks Vs Federal Cannabis Reform
2 Marijuana Stocks To Watch As The Market Faces Some Pullback The post Marijuana Stocks Vs Federal Cannabis Reform appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Goodness Growth Holdings, Inc. (GDNSF) CEO Kyle Kingsley on Q3 2021 Earnings Call Transcript
Goodness Growth Holdings, Inc. (GDNSF) CEO Kyle Kingsley on Q3 2021 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports